U.S., Aug. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07148843) titled 'Cannabidiol as an Adjunct Treatment for Alcohol Withdrawal and Craving' on Aug. 19.
Brief Summary: Cannabidiol (CBD), one of the most prevalent cannabinoids in cannabis (marijuana) has been shown to reduce alcohol withdrawal symptoms in laboratory animals. In people without alcohol use disorder (AUD), CBD has been show to be effective in reducing anxiety, sleep problems, and seizures; all of these are common symptoms of alcohol withdrawal. This randomized placebo-controlled clinical trial will evaluate the potential of CBD to improve alcohol withdrawal symptoms and reduce craving during acute abstinence among individuals with modera...